AKT1 and neuroblastoma: Recently, CUDC-907 has been demonstrated to inhibit both HDAC1 and HDAC2 as well as PI3K, Akt and mTOR expression and this resulted in an inhibition of NB tumor growth in a 3D spheroid tumor model [41].